Replies to post #117977 on Biotech Values

[oc631]

A couple of updates to GILD's previously unnamed Phase 1 HCV compounds




GS-5885 NS5A Inhibitor (active, not recruiting.)


http://clinicaltrials.gov/ct2/show/NCT01193478?term=GS-5885&rank=1



GS-6620 Nucleotide polymerase inhibitor (recruiting)



http://clinicaltrials.gov/ct2/show/NCT01316237?term=GS-6620&rank=1